BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18075378)

  • 41. Intramyocardial transplantation of bone marrow-derived stem cells: ultrasonic strain rate imaging in a model of hibernating myocardium.
    Schneider C; Krause K; Jaquet K; Geidel S; Malisius R; Boczor S; Rau T; Zienkiewicz T; Hennig D; Kuck KH
    J Card Fail; 2008 Dec; 14(10):861-72. PubMed ID: 19041051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stem cell transplantation in the treatment of terminal stage of coronary disease].
    Ge JB
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1329. PubMed ID: 15633284
    [No Abstract]   [Full Text] [Related]  

  • 43. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adult stem cell transplantation in autoimmune disease.
    Tyndall A; Gratwohl A
    Curr Opin Hematol; 2009 Jul; 16(4):285-91. PubMed ID: 19465851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
    Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
    Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stem cell transplantation for ischemic cardiomyopathy: hope or hype?
    Rao V
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1492-3. PubMed ID: 16307987
    [No Abstract]   [Full Text] [Related]  

  • 47. Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.
    Song SW; Chang W; Song BW; Song H; Lim S; Kim HJ; Cha MJ; Choi E; Im SH; Chang BC; Chung N; Jang Y; Hwang KC
    Stem Cells; 2009 Jun; 27(6):1358-65. PubMed ID: 19489098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stem cell therapy for ischemic heart disease: where are we?
    LaPar DJ; Kron IL; Yang Z
    Curr Opin Organ Transplant; 2009 Feb; 14(1):79-84. PubMed ID: 19337151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development.
    Matsuda R; Yoshikawa M; Kimura H; Ouji Y; Nakase H; Nishimura F; Nonaka J; Toriumi H; Yamada S; Nishiofuku M; Moriya K; Ishizaka S; Nakamura M; Sakaki T
    Cell Transplant; 2009; 18(1):39-54. PubMed ID: 19476208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of stem cells for ischemic cardiomyopathy--reply.
    Hare JM; Difede D; Heldman AW
    JAMA; 2013 Apr; 309(14):1458-9. PubMed ID: 23571573
    [No Abstract]   [Full Text] [Related]  

  • 51. Functional outcome of bone marrow stem cells (CD45(+)/CD34(-)) after cell therapy in chronic spinal cord injury in Wistar rats.
    Carvalho KA; Vialle EN; Moreira GH; Cunha RC; Simeoni RB; Francisco JC; Guarita-Souza LC; Oliveira L; Zocche L; Olandoski M
    Transplant Proc; 2008 Apr; 40(3):845-6. PubMed ID: 18455033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell therapy for ischaemic heart disease.
    Beeres SL; Atsma DE; van Ramshorst J; Schalij MJ; Bax JJ
    Heart; 2008 Sep; 94(9):1214-26. PubMed ID: 18703700
    [No Abstract]   [Full Text] [Related]  

  • 53. [Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up].
    Tayyareci Y; Umman B; Sezer M; Beşişik S; Sanli Y; Mudun A; Gürses N; Nişanci Y
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):519-29. PubMed ID: 19223717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction.
    Ghanem A; Steingen C; Brenig F; Funcke F; Bai ZY; Hall C; Chin CT; Nickenig G; Bloch W; Tiemann K
    J Mol Cell Cardiol; 2009 Sep; 47(3):411-8. PubMed ID: 19540842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stem cell therapy for myocardial repair.
    Weissberg PL; Qasim A
    Heart; 2005 May; 91(5):696-702. PubMed ID: 15831664
    [No Abstract]   [Full Text] [Related]  

  • 57. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke.
    Dharmasaroja P
    J Clin Neurosci; 2009 Jan; 16(1):12-20. PubMed ID: 19017556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beneficial effect of autologous transplantation of bone marrow stromal cells and endothelial progenitor cells on cerebral ischemia in rabbits.
    Chen ZZ; Jiang XD; Zhang LL; Shang JH; Du MX; Xu G; Xu RX
    Neurosci Lett; 2008 Nov; 445(1):36-41. PubMed ID: 18755241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regenerative heart failure therapy headed for optimization.
    Terzic A; Behfar A
    Eur Heart J; 2014 May; 35(19):1231-4. PubMed ID: 24670713
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical study on the improvement of ischemia condition with stem cell transplantation in 122 cases necrosis of femoral head].
    Yang XF; Wang HM; Xu YF; Zang YB; Wu YX; Lü X; Lü NW; Shan H
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(20):1428-31. PubMed ID: 18241601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.